题名 | ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: a prospective randomized pilot trial. |
作者 | Kim MJ1, Tsinalis D, Franz S, Binet I, Gürke L, Mihatsch MJ, Steiger J, Thiel G, Dickenmann M. |
杂志 | Ann Transplant. 2008;13(4):21-7. |
链接 | https://www.ncbi.nlm.nih.gov/pubmed/19034219 |
欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |